Signature d’une convention encadrant le financement
de Pharnext par Néovacs
LinKinVax finalise un nouveau tour de financement initié en 2022, d’un montant total de 7,3 M€
Inotrem Receives Funding from the Crohn’s & Colitis Foundation to help
develop new therapeutic approaches in Inflammatory Bowel Disease (IBD)
Brenus Pharma and InSphero receive €1.5 million in grants from the European EUROSTARS fund for the development of a companion test for the next-generation cancer cell immunotherapy STC-1010
